OFIX | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 15%

Liquidity 23%

Performance 0%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.06%

1 Month

-10.34%

3 Months

12.74%

6 Months

31.16%

1 Year

25.83%

2 Year

-10.34%

Key data

Stock price

$17.71

P/E Ratio

-5.53

DAY RANGE

$17.05 - $17.72

EPS

-$3.21

52 WEEK RANGE

$12.45 - $20.73

52 WEEK CHANGE

$25.02

MARKET CAP

665.768 M

YIELD

N/A

SHARES OUTSTANDING

38.175 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/06/2024

BETA

1.59

PUBLIC FLOAT

AVERAGE 10 VOLUME

$227,919

AVERAGE 30 VOLUME

$211,319

Company detail

CEO: Jon C. Serbousek
Region: US
Website: orthofix.com
Employees: 1,090
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures.

OFIX - Orthofix Medical Inc.